000 01676 a2200481 4500
005 20250517014135.0
264 0 _c20160510
008 201605s 0 0 eng d
022 _a1365-2265
024 7 _a10.1111/cen.12730
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, Paul
245 0 0 _aWhat is the optimal bone-preserving strategy for patients with Addison's disease?
_h[electronic resource]
260 _bClinical endocrinology
_cAug 2015
300 _a157-61 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAddison Disease
_xcomplications
650 0 4 _aAndrogens
_xmetabolism
650 0 4 _aBone Density
650 0 4 _aBone and Bones
_xdiagnostic imaging
650 0 4 _aDehydroepiandrosterone Sulfate
_xchemistry
650 0 4 _aElectrolytes
650 0 4 _aFemale
650 0 4 _aFemur Neck
_xpathology
650 0 4 _aGas Chromatography-Mass Spectrometry
650 0 4 _aGlucocorticoids
_xmetabolism
650 0 4 _aHip Fractures
_xprevention & control
650 0 4 _aHormones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xmetabolism
650 0 4 _aHyponatremia
_xblood
650 0 4 _aHypothyroidism
_xcomplications
650 0 4 _aMiddle Aged
650 0 4 _aOsteoporotic Fractures
_xprevention & control
650 0 4 _aRadiography
650 0 4 _aRenin
_xblood
650 0 4 _aRisk
650 0 4 _aSpine
_xpathology
650 0 4 _aVitamin D
_xanalogs & derivatives
700 1 _aGreenfield, Jerry R
773 0 _tClinical endocrinology
_gvol. 83
_gno. 2
_gp. 157-61
856 4 0 _uhttps://doi.org/10.1111/cen.12730
_zAvailable from publisher's website
999 _c24584060
_d24584060